Progene Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 22.97%
(FY 2022)
- Profit 32.72%
(FY 2022)
- Ebitda -45.40%
(FY 2022)
- Net Worth 101.10%
(FY 2022)
- Total Assets 16.62%
(FY 2022)
About Progene Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Haider Syed and Amena Abbas serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC160270
- Company No.
160270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Progene Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Haider Syed  | Director | 06-Mar-2006 | Current |
| Amena Abbas | Director | 12-Jan-2019 | Current |
Financial Performance of Progene Pharma.
Progene Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.97% increase. The company also saw a substantial improvement in profitability, with a 32.72% increase in profit. The company's net worth Soared by an impressive increase of 101.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Progene Pharma?
Unlock access to Progene Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Progene Pharma?
Unlock and access historical data on people associated with Progene Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Progene Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progene Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
